ADM Tronics Unlimited, Inc. is preparing for the upcoming commercial introduction of its Vet-Sonotron®?, non-invasive pain treatment device for the veterinary market with marketing and distribution agreements and the launch of a new website - As previously announced, ADMT released evaluation units of the Vet-Sonotron for the animal therapy markets. Users reported very favorable results in treating musculoskeletal conditions in small animals and horses. Based on the successful evaluations ADMT finalized the design and began preparations for commercial production.

This was delayed due to supply chain disruptions for electronic components. ADMT overcome this by redesigning sections of the Vet-Sonotronic and is now preparing for the first production run. In anticipation of the coming availability of the commercial version of the Vet-SonotRON, ADMT has taken steps for marketing and sales, and has launched a new website which allows those interested in purchasing the Vet-Sonotron to sign up for the advance notice list.

Large numbers of dogs require treatment to reduce pain from injuries or illnesses such as osteoarthritis. According to The American College of Veterinary Surgeons, osteoarthritis (OA) is common in dogs, affecting approximately one quarter of the population. The PRFT output is emitted through a hand-held applicator applied non-invasively to the treatment area.

Vet-Sonotron creates a microprocessor-controlled 15-second output of the PRFT discharge - termed a "Treatment Unit" or "TU". The number of TUs administered depends on the size and density of the treatment area with a typical treatment lasting only minutes. Depending on the severity of the condition treated, multiple treatment sessions are administered to achieve optimum results.

ADMT is developing a medical version of the Sonotron for use on humans where the need for effective pain treatment without the use of drugs or opioids is very large and unmet.